Medtronic has announced the first subject enrolment in the Peripheral Onyx Liquid Embolic (PELE) trial. The study aims to ...

Medtronic said its market-leading LigaSure technology can now be used with its Hugo soft tissue robotic surgery system in ...

With EU CE mark clearance for LigaSure RAS, Medtronic expands the Hugo system’s capabilities in gynaecologic and urologic ...

Medtronic announced today that it received CE mark for its LigaSure vessel sealing technology for use with its Hugo system.

Investors are increasingly eyeing the fast-growing MedSurg equipment space, which is projected to witness a compound annual growth rate (CAGR) of 9.54% from 2025 to 2030 (per Grand View Research). Two ...

Ligasure Healthcare Private Limited is majorly in Manufacturing (Metals & Chemicals, and products thereof) business and currently, company operations are active. Company is registered in Kolkata (West ...

Medtronic has worked with nonprofit SpineHope to give more than 200 children life-changing medical treatment since 2008 NORTHAMPTON, MA / ACCESS Newswire / July 16, 2025 / As kids go, Monica Santamari ...

The aim of this study was to make a comparison between the tissue fusion technique and conventional methods for sealing bowel anastomosis. Eighteen female domestic pigs (Suidae, Sus) were used in our ...

Medtronic plc (NYSE: MDT) Q3 2025 Earnings Conference Call February 18, 2025 8:00 AM ET Company Participants Ryan Weispfenning - Vice President and Head of Investor Relations Geoff Martha ...

Find earnings, economic, stock splits and IPO calendars to track upcoming financial events from Yahoo Finance.

He also anticipates adding the company’s LigaSure vessel-sealing technology to Hugo in 2025. Hugo is a modular, multi-quadrant platform designed for various surgical procedures.